Connection
Scot Sedlacek to Poly-ADP-Ribose Binding Proteins
This is a "connection" page, showing publications Scot Sedlacek has written about Poly-ADP-Ribose Binding Proteins.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.025 |
|
|
|
-
Jones SE, Collea R, Paul D, Sedlacek S, Favret AM, Gore I, Lindquist DL, Holmes FA, Allison MAK, Brooks BD, Portillo RM, Vukelja SJ, Steinberg MS, Stokoe C, Crockett MW, Wang Y, Asmar L, Robert NJ, O'Shaughnessy J. Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study. Lancet Oncol. 2013 Oct; 14(11):1121-1128.
Score: 0.025